Cover: Sodium butyrate, a histone deacetylase inhibitor, ameliorates neuromuscular phenotypes of a transgenic mouse model of
spinal and bulbar muscular atrophy. A male transgenic mouse treated with 4 g/l of sodium butyrate (left) shows normal body size,
although the non-treated one (right) demonstrates a striking muscular atrophy. The footsteps are those of the non-treated mouse.
Front paws are in red, and hind paws in blue. See Article by Minamiyama et al., in this issue, pp.1183–1192.
[Table of Contents]